The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $1,867.25 to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of 4,566,689,724 units of the pharmaceutical product DUPIXENT 300 MG/2 ML SYRINGE 2ML. This delivery order is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, valued at $999,999,999.00, which enables the company to provide a wide range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. The delivery order has a period of performance through December 12, 2024. The contract is an unrestricted, non-set-aside award, indicating Dakota Drug, Inc.'s competitive position in the federal marketplace.
Generated 3/12/25, 9:49 AM